An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Vertex Pharmaceuticals (NASDAQ: VRTX) will announce its fourth quarter and full year 2022 financial results on February 7, 2023, after market close. A conference call will follow at 4:30 p.m. ET, accessible by phone or via a live webcast on the company's website. Vertex is a leading biotechnology firm focused on innovative therapies for serious diseases, particularly cystic fibrosis. With multiple approved drugs and an extensive pipeline targeting various genetic and severe conditions, Vertex is positioned as a significant player in the biotech sector. The company is also recognized as a top employer within the industry.
Positive
Vertex has multiple approved medicines for cystic fibrosis.
The company is advancing a robust clinical pipeline in various serious diseases.
Negative
None.
BOSTON--(BUSINESS WIRE)--
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2022 financial results on Tuesday, February 7, 2023 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (877) 270-2148 (U.S.) or +1(412) 902-6510 (International) and reference the “Vertex Pharmaceuticals Fourth Quarter 2022 Earnings Call”.
The conference call will be webcast live and a link to the webcast can be accessed through Vertex's website at www.vrtx.com in the "Investors" section. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An archived webcast will be available on the company's website.
About Vertex
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust clinical pipeline of investigational small molecule, cell and genetic therapies in other serious diseases where it has deep insight into causal human biology, including sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, pain, type 1 diabetes, and alpha-1 antitrypsin deficiency.
Founded in 1989 in Cambridge, Mass., Vertex's global headquarters is now located in Boston'sInnovation District and its international headquarters is in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 13 consecutive years on Science magazine's Top Employers list and one of Fortune’s Best Workplaces in Biotechnology and Pharmaceuticals and Best Workplaces for Women. For company updates and to learn more about Vertex's history of innovation, visit www.vrtx.com or follow us on Facebook, Twitter, LinkedIn, YouTube and Instagram.
When will Vertex Pharmaceuticals report its fourth quarter 2022 results?
Vertex Pharmaceuticals will report its fourth quarter and full year 2022 financial results on February 7, 2023, after market close.
How can I access the Vertex Pharmaceuticals earnings call?
The earnings call for Vertex Pharmaceuticals can be accessed by dialing (877) 270-2148 for U.S. callers or +1(412) 902-6510 for international callers, or through a live webcast on their website.
What is the focus of Vertex Pharmaceuticals' clinical pipeline?
Vertex Pharmaceuticals focuses on developing treatments for cystic fibrosis and several other serious diseases, including sickle cell disease and beta thalassemia.
Is Vertex Pharmaceuticals recognized as a top employer?
Yes, Vertex Pharmaceuticals has been recognized as one of the industry's top places to work, including 13 consecutive years on Science magazine's Top Employers list.
